Angle Share Discussion Threads

[mcdermov] 18/1/2023 13:37

Hysterical short talk is irrelevant in the face of certain facts.Angle's liquid biopsy platform is FDA approved and has impressive results for the detection of ovarian carcinoma, a killer disease for which there is at the moment no adequate screening test, last year's major international study, which did not include a liquid biopsy test proved this.Grant Dollens Global Frontier hedge fund has just taken a 3%+ stake in Angle.His last major AIM investment WANDisco has almost quadrupled in value in the past year.I would certainly regard shorting this share as a high risk, almost reckless endeavour.

[gspanner] 18/1/2023 13:30

I suppose short sellers may have bought back when they knew of forced fund redemptions… And taken advantage of that liquidity… who know maybe the funds are still at it.

[ih_361860] 18/1/2023 13:29

ASTRAL - give it a rest (yawn). Don’t think you’ve every contributed anything remotely intelligent to this group. If you have no position here, why do you spend all day here talking nonsense. Obvious shorter

[niaroo] 18/1/2023 13:29

Chesty1 Yes this is a traders stock. I think it will hit 24. Just look for the same names appearing and talking the stock up and moving it up taking small profits 10 -20% over a week or so. just don't be to greedy.

[astralv1si0n] 18/1/2023 13:25

Like I’ve said before, take your money out of here while you still have some and invest in stocks NOT on AIM. LETSBUY1 should be back with a revised prediction at some point. Absolute I.DIOT probably embarrassed while at the job centre. Silly lad.

[joinednow] 18/1/2023 13:20

well news could come in the form of a holding rns anytime.

huge huge vols of late.

who snapped up the shares?

[bones698] 18/1/2023 13:15

There aren't enough buyers to keep up any momentum . Agl isn't in the news and goes under the radar because eof the constant delays to deals and other issues .
Without buyers the share price drifts . Fast becoming a news driven shareprice only and news is very slow ,certainly news that impacts the sharepeice anyway .
People getting fed up or looking for fast money don't have the patience to wait for this . After the last RNs can hardly blame them

[parob] 18/1/2023 12:27

Yes I've added a few down here too.Now onwards to make a higher high!

[kimchi1] 18/1/2023 12:26

Added few under 28p - retrace seems overdone now

[gspanner] 18/1/2023 11:52

Liquidity settling down. Personally I think this has been shorted from a long way above here following the bubble/deflation; FDA approval/Newlands comments right down to the low 20s… Up to the point when the hedge fund bought.

Now things have settled my impression is the hedge fund is still buying shares as they become available, (likely aware of the short position), but also happy to wait whilst bored PIs/traders sell and scoop them up.

[joinednow] 18/1/2023 11:48

its always been a traders stock , look back at 10 years history, up and down like a yo yo.

Is this the final spin?

bidders surely circling at this price.

[chesty1] 18/1/2023 11:41

This has now become a traders stock....Just not good enough at trading to try it.

[joinednow] 18/1/2023 11:29

classic sawtooth up chart pattern

[parob] 18/1/2023 11:27

Bottom of the dip/higher low on the chart going in today imo.

[gregb] 18/1/2023 10:46

The only thing Angle injects is a needle for a blood draw ffs!

[dexdringle] 18/1/2023 10:41

....better that than some new untested experimental s#it injected into hundreds of millions of people with no regard for the consequences....

[gregb] 18/1/2023 10:15

I'd be very surprised if a 50 year old oncology drug passed current FDA regs!

[divmad] 18/1/2023 10:04

The purpose of their P1a trial was not to show efficacy, but safety at increasing dosages of an existing 50-year old FDA-approved cancer drug.

[sicilian_kan] 18/1/2023 09:23

Avacta's rns is very promising, but I would far rather be in Angle. Avacta's market cap of £431m is extremely high for something just in the middle of Phase 1, the company has a poor track record in terms of relying on company statements and external validation (lft debacle), and there has been no evidence in the rns of tumour shrinkage. Yes Avacta may take off even further, yes it might be the real deal, but it is still very, very risky. Angle I see as far less risky (fda approval, world class ovarian results etc etc) but with equally good upside and a wonderful entry point with the current share price. Horses for courses.

[parob] 18/1/2023 09:21

Can't be many more 23-26p buyers to shake out now before it starts moving up.

[astra1vision] 17/1/2023 21:28

LETSBUY1 very angry. Silly lad.

[letsbuy1] 17/1/2023 20:26

Still haven’t decided to play with the Train
Hahah what made me laugh.. The south of france.. is that what you call council houses these days.. scum

[bones698] 17/1/2023 19:45

hxxps://ukinvestormagazine.co.uk/avacta-shares-are-now-on-the-verge-of-ftse-aim-greatness/

Looks like this was the one to be in and where the M&A idea has come from . They seem to be moving a lot faster than agl and getting the spot light too .
Might mean things speed up a bit here at least

[astra1vision] 17/1/2023 19:34

LETSBUY1 now changed his tune to 40p this week. Do I hear 35?? Poor lad.